anubhai
Back OfficeNippon India Pharma Fund - Direct (Bonus)
Summary
| Fund Name | Nippon India Mutual Fund |
| Scheme Name | Nippon India Pharma Fund - Direct (Bonus) |
| AMC | Nippon India Mutual Fund |
| Type | Open |
| Category | Equity - Pharma |
| Launch Date | 01-Jan-2013 |
| Fund Manager | Sailesh Raj Bhan |
| Net Assets(Rs. cr) | 8,346.49 |
NAV Graph
| One Month | Three Month | Six Month | One Year | Three Year | Five Year |
Latest Payouts
| Dividends | Bonus |
|---|
Performance
| 1 Week (%) | 1 Month (%) | 3 Month (%) | 6 Month (%) | 1 Year (%) | 3 Year (%) | 5 Year (%) | Since INC (%) | |
|---|---|---|---|---|---|---|---|---|
| Scheme Return | -0.91 | -0.35 | 0.57 | 1.77 | 0.37 | 22.05 | 17.16 | 17.67 |
| Category Avg | -0.98 | -1.14 | 0.01 | 3.31 | -0.72 | 22.26 | 16.74 | 14.93 |
| Category Best | -0.36 | 0.95 | 2.11 | 7.99 | 6.11 | 27.76 | 19.68 | 30.50 |
| Category Worst | -1.97 | -2.47 | -1.85 | -3.14 | -7.48 | 18.33 | 12.67 | -4.22 |
Asset Allocation
Holdings
| Company Name | % Hold |
|---|---|
| Sun Pharma.Inds. | 12.67 |
| Divi's Lab. | 8.07 |
| Lupin | 7.26 |
| Cipla | 6.29 |
| Apollo Hospitals | 5.97 |
| Dr Reddy's Labs | 5.62 |
| Vijaya Diagnost. | 3.42 |
| Medplus Health | 3.32 |
| Gland Pharma | 3.05 |
| Glaxosmi. Pharma | 2.87 |
| Ajanta Pharma | 2.83 |
| Sai Life | 2.81 |
| Thyrocare Tech. | 2.59 |
| Abbott India | 2.39 |
| Aurobindo Pharma | 2.32 |
| Dr Lal Pathlabs | 2.29 |
| Mankind Pharma | 2.16 |
| Alkem Lab | 2.14 |
| Biocon | 2.10 |
| J B Chemicals & | 2.01 |
| Pfizer | 1.99 |
| Narayana Hrudaya | 1.95 |
| Ipca Labs. | 1.50 |
| Suraksha Diagno. | 1.48 |
| Fortis Health. | 1.35 |
| Sanofi India | 1.32 |
| Sanofi Consumer | 1.24 |
| Max Healthcare | 1.23 |
| Syngene Intl. | 1.00 |
| Anthem Bioscienc | 0.90 |
| Akums Drugs | 0.84 |
| Emcure Pharma | 0.74 |
| Astrazeneca Phar | 0.72 |
| Indoco Remedies | 0.61 |
| Orchid Pharma | 0.43 |
| Concord Biotech | 0.19 |
| TREPS | 0.47 |
| Net CA & Others | -0.14 |
| C C I | 0.00 |
